The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial
Open accessAbstract
Background and Purpose— To demonstrate that paramedic initiation of intravenous magnesium sulfate (Mg) in the field in focal stroke patients is feasible, safe, and yields significant time-savings compared with in-hospital initiation of neuroprotective therapy. Methods— We performed an open-label clinical trial. Inclusion criteria were: (1) likely stroke as identified by the Los Angeles Prehospital Stroke Screen; (2) age 45 to 95; and (3) treatment initiation within 12 hours of symptom onset. Paramedics initiated 4 g Mg loading dose in the field, followed by 16 g over 24 hours in hospital. Results— Twenty patients were enrolled, with mean age 74 (range 44 to 92), and 50% were male. Final diagnosis was acute cerebrovascular disease in all (ischemic 80%, hemorrhagic 20%). Study agent infusion began a median of 100 minutes after symptom onset (range 24 to 703), and 70% received study agent within 2 hours of onset. The interval from paramedic arrival on scene to study agent start was: field-initiated, 26 minutes (range 15 to 64) versus in-hospital initiated (historic controls), 139 minutes (range 66 to 300; P <0.0001). Paramedics rated patient status on hospital arrival as improved 20%, worsened 5%, and unchanged 75%. Median NIHSS on hospital arrival was 11 in all patients and 16 in patients unchanged since field treatment start. Good functional outcome at 3 months (Rankin ≤ 2) occurred in 60%. No serious adverse events were associated with field therapy initiation. Conclusions— Field initiation of Mg sulfate in acute stroke patients is feasible and safe. Prehospital trial conduct substantially reduces on-scene to needle time and permits hyperacute delivery of neuroprotective therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kidwell, C. S., Starkman, S., Eckstein, M., Weems, K., & Saver, J. L. (2000) · Stroke · doi:10.1161/01.str.31.1.71 · Cited by 426
Self-citationClinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?
De Keyser, J., Sulter, G., & Luiten, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01463-0 · Cited by 374
Trends in Acute Ischemic Stroke Trials Through the 20th Century
Kidwell, C. S., Liebeskind, D. S., Starkman, S., & Saver, J. L. (2001) · Stroke · doi:10.1161/01.str.32.6.1349 · Cited by 246
Self-citationFisher, M. (2003) · Stroke · doi:10.1161/01.str.0000072983.64326.53 · Cited by 188
Early Dramatic Recovery During Intravenous Tissue Plasminogen Activator Infusion
Felberg, R. A., Okon, N. J., El‐Mitwalli, A., Burgin, W. S., Grotta, J. C., & Alexandrov, A. V. (2002) · Stroke · doi:10.1161/01.str.0000015556.48283.74 · Cited by 134
Neuroprotective agents for the treatment of acute ischemic stroke
Ovbiagele, B. I., Kidwell, C. S., Starkman, S., & Saver, J. L. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0031-z · Cited by 123
Self-citationDose Optimization of Intravenous Magnesium Sulfate After Acute Stroke
Muir, K. W., & Lees, K. R. (1998) · Stroke · doi:10.1161/01.str.29.5.918 · Cited by 113
Llanes, J. N., Kidwell, C. S., Starkman, S., Leary, M. C., Eckstein, M. K., & Saver, J. L. (2004) · Prehospital Emergency Care · doi:10.1080/312703002806 · Cited by 112
Self-citationGrossman, M., Payer, F., Onishi, K., D’Esposito, M., Morrison, D. F., Sadek, A. G., & Alavi, A. A. (1998) · Neurology · doi:10.1212/wnl.50.1.157 · Cited by 74
Jonas, S., Aiyagari, V., Vieira, D. L., & FIGUEROA, M. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03633.x · Cited by 37
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Self-citationGlutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Self-citationLees, K. R., Bluhmki, E., von Kummer, R., Brott, T. G., Toni, D., Grotta, J. C., Albers, G. W., Kaste, M., Marler, J. R., Hamilton, S. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60491-6 · Cited by 2,184
Magnesium in man: implications for health and disease
de Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2015) · Physiological Reviews · doi:10.1152/physrev.00012.2014 · Cited by 1,726
Metadata
- Authors
- Saver, J. L., Kidwell, C., Eckstein, M., & Starkman, S.
- Venue
- Stroke
- Published
- 2004-05
- Volume
- 35
- Issue
- 5
- Pages
- e106-8
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2016656772
- Cited by
- 252
- References
- 10
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial. https://app.cochat.ai/papers/10.1161/01.str.0000124458.98123.52
- The paper
- Saver, J. L., Kidwell, C., Eckstein, M., & Starkman, S. (2004). Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial. Stroke. https://doi.org/10.1161/01.str.0000124458.98123.52
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.